Robust therapeutic effects on COVID-19 of novel small molecules: Alleviation of SARS-CoV-2 S protein induction of ACE2/TMPRSS2, NOX2/ROS, and MCP-1

By sjmartinez • October 4, 2022

Youn JY, Wang J, Li Q, Huang K, Cai H. Robust therapeutic effects on COVID-19 of novel small molecules: Alleviation of SARS-CoV-2 S protein induction of ACE2/TMPRSS2, NOX2/ROS, and MCP-1. Front Cardiovasc Med. 2022 Sep 15;9:957340. doi: 10.3389/fcvm.2022.957340. PMID: 36187008; PMCID: PMC9520320.

Tags: acute respiratory distress syndrome (ARDS), Cardiology/Epi, covid-19, endothelial dysfunction, NADPH oxidase isoform 2 (NOX2), Publications, SARS-CoV-2

Noninvasive in vivo deoxycytidine kinase (dCK)-PET identifies tumor-draining lymph nodes upon immune checkpoint inhibitor therapy

Philippe C, Cotton J, Bowden GD, Pöschel S, Knopf P, Schörg B, Gonzalez-Menendez I, Sonanini D, Flatz L, Allen-Auerbach M, Radu CG, Czernin J, Quintanilla-Martinez[...]

Design and Rationale of the WARRIOR Ancillary Study for Coronary CT Angiographic Analysis

Tamarappoo B, Wolny R, Tomasino GF, Berman D, Handberg E, Pepine CJ, Lo MC, Budoff M, Shaw L, Shufelt C, Wei J, Gulati M, Merz[...]

Ethnic differences in left ventricular myocardial volume assessed by coronary computed tomography angiography in asymptomatic adults

Zahraee S, Beshoy I, Kinninger A, Mao SS, Budoff MJ. Ethnic differences in left ventricular myocardial volume assessed by coronary computed tomography angiography in asymptomatic[...]